These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 3648856)

  • 21. A stage model of HTLV-III LAV infection in intravenous drug users.
    Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
    NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
    [No Abstract]   [Full Text] [Related]  

  • 22. [Visceral leishmaniasis associated with positive anti-HTLV III antibody].
    Verdejo J; Alvar J; Polo RM; González Lahoz JM
    Rev Clin Esp; 1987 Mar; 180(4):221. PubMed ID: 3647541
    [No Abstract]   [Full Text] [Related]  

  • 23. [LAV/HTLV-III infection among a group of homosexual men; prevalence and psychosocial factors].
    van Griensven GJ; Tielman RA; Goudsmit J; van der Noordaa J; de Wolf F; Coutinho RA
    Ned Tijdschr Geneeskd; 1986 Nov; 130(48):2178-80. PubMed ID: 3492678
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic generalized lymphadenopathy with splenomegaly associated with HTLV-III virus antibodies].
    Mijović A; Stevanović G; Brkić S; Dimitrijević M; Rolović Z; Ruvidić R
    Srp Arh Celok Lek; 1986 Jan; 114(1):109-20. PubMed ID: 3014667
    [No Abstract]   [Full Text] [Related]  

  • 25. [HTLV-III monitoring in prostitutes in Vienna].
    Kopp W; Dangl-Erlach E
    Wien Klin Wochenschr; 1986 Oct; 98(20):695-8. PubMed ID: 3466478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia.
    Robert-Guroff M; Giardina PJ; Robey WG; Jennings AM; Naugle CJ; Akbar AN; Grady RW; Hilgartner MW
    J Immunol; 1987 Jun; 138(11):3731-6. PubMed ID: 3495568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic abnormalities and antibodies to HTLV-III in asymptomatic drug addicts.
    Ortona L; Laghi V; Tamburrini E; Nervo P; Cauda R
    Ala J Med Sci; 1987 Jan; 24(1):46-51. PubMed ID: 3644604
    [No Abstract]   [Full Text] [Related]  

  • 28. Isolation of HTLV III/LAV from drug addicts in Palermo.
    Romano N; Portera M; Vitale F; Russo Alesi D; Torregrossa MV; Perrera G
    Microbiologica; 1987 Jan; 10(1):73-80. PubMed ID: 3646455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for antibody to HTLV-III in blood donors of Liguria. Ligurian Committee for the Study of Infections Transmitted through Blood and Blood Products.
    Boll Ist Sieroter Milan; 1985; 64(5):363-6. PubMed ID: 3004542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome.
    Lazzarin A; Uberti Foppa C; Galli M; Mantovani A; Poli G; Franzetti F; Nóvati R
    Clin Exp Immunol; 1986 Jul; 65(1):105-11. PubMed ID: 3791696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [AIDS and the community. Preliminary data of an epidemiological study].
    De Mercato R; Siciliano V; Formisano S; Belmonte D; Noce S; Rovito G; Ciampi R; Perna V; Fratellanza G
    Minerva Med; 1988 Sep; 79(9):779-82. PubMed ID: 3173760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of antibodies against human T-lymphotropic virus type III (HTLV-III) in parenteral drug addicts in the Barcelona area].
    Muga R; Tor J; Argelagués E; Rey-Joly C; Foz M; Ribas-Mundó M
    Med Clin (Barc); 1986 Jan; 86(3):97-9. PubMed ID: 3457230
    [No Abstract]   [Full Text] [Related]  

  • 33. [Human T-lymphotropic virus (HTLV-III) antibodies in intravenous drug addicts from the Valencia community].
    Rodrigo JM; Serra MA; Aguilar E; Ample I; Gimeno V; del Olmo JA; Escudero A; Aparisi L; Wassel A; Sanmartín B
    Med Clin (Barc); 1986 Jan; 86(3):89-92. PubMed ID: 3007886
    [No Abstract]   [Full Text] [Related]  

  • 34. Monoclonal-oligoclonal immunoglobulins in HTLV III infected subjects: HTLV III-induced or HTLV III-associated?
    Sala PG; Mazzolini S; Tonutti E; Crucil C; Pitzus E; Bramezza M
    Boll Ist Sieroter Milan; 1987; 66(1):14-7. PubMed ID: 3040040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombopenic purpura in a group of addicts addicted to parenteral drugs with anti-HTLV-III/LAV antibodies and inversion of the T-helper/T-suppressor cell quotient].
    Aguilar Ligorti E; Guix García J; Ample Guillén I; Balaguer Martínez JV; Marugán de la Concha I; García-Conde Bru J
    Sangre (Barc); 1986; 31(4):401-10. PubMed ID: 2947340
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug addiction and HIV infection. Changes in immunohematological parameters and clinical picture in a cohort of drug addicts after 1-year follow-up].
    Confalonieri F; Minora T; Pedretti D; Villa A; Mariani L
    Clin Ter; 1988 Oct; 127(1):3-15. PubMed ID: 2976339
    [No Abstract]   [Full Text] [Related]  

  • 37. Italian HIV infection updated.
    Luzi G; Aiuti F; Rezza G; Greco D
    Nature; 1987 Jul 30-Aug 5; 328(6129):385-6. PubMed ID: 3475576
    [No Abstract]   [Full Text] [Related]  

  • 38. [Analysis of antibodies to human T-lymphotropic type III virus (anti-HTLV III) in a population at high risk for AIDS in Yugoslavia].
    Burek V; Sakoman S; Hudolin V; Kovać D; Ficović P; Cepelja Z; Petricević I; Schönwald S; Soldo I; Borcić D
    Lijec Vjesn; 1987 Jun; 109(6):216-9. PubMed ID: 3477674
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunological and cytochemical changes in groups at risk for acquired immunodeficiency syndrome and in symptomatic and asymptomatic carriers of antibodies to human immunodeficiency virus. A multivariate study].
    Gutiérrez Martín M; Romero Colás MS; Callén Sevilla L; Lasierra Díaz P; Larrad Mur L
    Med Clin (Barc); 1987 Oct; 89(13):544-8. PubMed ID: 3320599
    [No Abstract]   [Full Text] [Related]  

  • 40. [HTLV-III infection in risk groups].
    Esteban R; Buti M; Esteban JI; Hernández JM; Jardí R; Vila M; Tusell J; Guardia J
    Med Clin (Barc); 1986 Jan; 86(3):110-2. PubMed ID: 3007880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.